Northwest Biotherapeutics reported 892K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Applied Genetic Technologies AGTC:US $ 0.04M 0M
AstraZeneca AZN:LN 387M 59M
Bristol Myers Squibb BMY:US $ 292M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0.01M
Cti Biopharma CTIC:US $ 0.1M 0M
Cytori Therapeutics CYTX:US $ 0.02M 0M
Cytrx CYTR:US 38.78K 2K
Eisai 4523:JP Y 44986M 0M
Genocea Biosciences GNCA:US $ 0.06M 0M
Infinity Pharmaceuticals INFI:US $ 0.09M 0M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Northwest Biotherapeutics NWBO:US 892K 35K